Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Zh Nevrol Psikhiatr Im S S Korsakova ; 123(5. Vyp. 2): 69-75, 2023.
Article in Russian | MEDLINE | ID: mdl-37276001

ABSTRACT

OBJECTIVE: To determine the predictive role of periodic limb movements in sleep (PLMS) in cerebral small vessel disease (cSVD) progression rate. MATERIAL AND METHODS: Fifty patients with cSVD, aged 60-75 y.o., were enrolled. The study protocol included MRI assessment of white matter hyperintensities (WMH), nocturnal actigraphy and cognitive assessment. Depending on the PLMS, the main (PLM index ≥15) and the control (PLM index <15) groups were formed. The second visit was carried out in one year follow-up period, the examination consisted of brain MRI and cognitive assessment under the same protocol. ANCOVA was performed to determine if PLMS influence the degree of MRI- and neuropsychological changes. RESULTS: A significant effect of PLMS on the increase in the volume of WMH was revealed, both in the form of an increase in the index by more than 15 movements per hour (p=0.03), and quantitatively in the form of a connection with the index value (p=0.048). The influence of PLMS on the progression of cognitive dysfunction has not been found, however, it has been shown that the presence of PLMS is associated with lesions in the deep white matter (r=0.42, p<0.0001), and the results of neuropsychological tests are associated with lesions in the periventricular and juxtacortical WMH (p < 0.05 for each test). CONCLUSION: PLMS predict WMH progression in cSVD.


Subject(s)
Cerebral Small Vessel Diseases , Nocturnal Myoclonus Syndrome , Humans , Nocturnal Myoclonus Syndrome/complications , Nocturnal Myoclonus Syndrome/diagnosis , Prospective Studies , Movement , Sleep , Cerebral Small Vessel Diseases/complications , Cerebral Small Vessel Diseases/diagnostic imaging
2.
Zh Nevrol Psikhiatr Im S S Korsakova ; 121(11): 111-118, 2021.
Article in Russian | MEDLINE | ID: mdl-34932296

ABSTRACT

Pain is influenced by multiple emotional and cognitive factors. This paper provides an overview of the most important emotional and cognitive factors affecting pain, which has been confirmed in experimental and clinical studies. Emotional factors that increase pain perception include anxiety, depression, and other negative emotions. Positive emotions lead to a decrease in pain. Cognitive factors such as attention, expectation anxiety, and pain assessment can both increase and decrease pain sensations, depending on their specific focus. It becomes clear that pain is not just a reflection of nociceptive irritation, but also a feeling formed by psychological factors that can be individual in each case.


Subject(s)
Emotions , Pain , Anxiety/etiology , Cognition , Depression/etiology , Humans , Pain/etiology , Pain Perception
3.
Adv Gerontol ; 34(3): 345-351, 2021.
Article in Russian | MEDLINE | ID: mdl-34409812

ABSTRACT

Cognitive impairment is one of the most common causes of reduced quality of life in older people. The aim of the study to evaluate impact of functional status, physical health and cognitive functions in women aged 55-64 years old. The study included 250 women aged 55-64 years (mean age 59,3±2,9 years). Socio-demographic and economic factors, functional and cognitive status were analyzed, the presence and prevalence of geriatric syndromes and their association with social, demographic and economic characteristics, risk factors for the development of chronic non-communicable diseases were studied. The prevalence of cognitive impairments was independently associated with education level, low income of patients, diabetes mellitus, glomerular filtration rate, and vertebral artery diameter. In this case, the level of education was a protective factor.


Subject(s)
Cognitive Dysfunction , Quality of Life , Aged , Cognition , Cognitive Dysfunction/diagnosis , Cognitive Dysfunction/epidemiology , Female , Functional Status , Geriatric Assessment , Humans , Prevalence , Risk Factors
4.
Adv Gerontol ; 30(3): 450-456, 2017.
Article in Russian | MEDLINE | ID: mdl-28849893

ABSTRACT

The paper presents original study results of cognitive changes associated with aging in the absence of neurodegenerative, vascular and other significant for cognition disorders in period from 50 to 85 years. It was shown that aging is associated with moderate memory decrease predominantly because of retrieval deficit but not acquisition insufficiency. It was also shown that aging is associated with non-severe executive dysfunction (lack of planning and control). According usual neuropsychological approaches pattern of cognitive changes described above reflects anterior cortical dysfunction or/and impaired interaction between frontal lobes and subcortical basal ganglia. Shows what physiological changes occur with age in the field of memory and executive functions, which is of great clinical importance for the differential diagnosis of normal aging and early stages of common in the elderly cerebral diseases.


Subject(s)
Aging/physiology , Cognition Disorders/physiopathology , Cognition/physiology , Aged , Aged, 80 and over , Cognition Disorders/diagnosis , Diagnosis, Differential , Executive Function/physiology , Humans , Middle Aged , Neuropsychological Tests
5.
Neurosci Behav Physiol ; 38(6): 639-45, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18607744

ABSTRACT

The efficacy of treatment with cerebrolysin was studied in 40 patients with cerebral vascular insufficiency. Cerebrolysin (20 daily i.v. infusions of 10 ml in 200 ml of physiological saline) was found to be an effective means of treating this group of patients. Courses of cerebrolysin treatment decreased the severity of memory and attention impairments, improving the overall cognitive status of the patients. Clinical observations and neuropsychological testing were supported by electrophysiological results, in terms of the P300 cognitive evoked potential. The effects of treatment at the doses used here were delayed and were seen three months after completion of treatment.


Subject(s)
Amino Acids/therapeutic use , Cerebrovascular Disorders/drug therapy , Cognition Disorders/prevention & control , Event-Related Potentials, P300/drug effects , Nootropic Agents/therapeutic use , Adult , Aged , Aged, 80 and over , Attention/drug effects , Brain/blood supply , Brain/drug effects , Brain/physiopathology , Cerebrovascular Disorders/complications , Cognition Disorders/etiology , Concept Formation/drug effects , Female , Humans , Male , Middle Aged , Neuropsychological Tests , Neurotensin/physiology , Problem Solving/drug effects , Severity of Illness Index , Statistics, Nonparametric
SELECTION OF CITATIONS
SEARCH DETAIL
...